• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

格拉斯哥血压诊所患者的死亡率。

Mortality in patients of the Glasgow Blood Pressure Clinic.

作者信息

Isles C G, Walker L M, Beevers G D, Brown I, Cameron H L, Clarke J, Hawthorne V, Hole D, Lever A F, Robertson J W

出版信息

J Hypertens. 1986 Apr;4(2):141-56. doi: 10.1097/00004872-198604000-00003.

DOI:10.1097/00004872-198604000-00003
PMID:3711657
Abstract

The mortality of 3783 non-malignant hypertensive patients attending the Glasgow Blood Pressure Clinic between 1968 and 1983 and followed for an average of 6.5 years was compared with that in three control groups: the general population of Strathclyde a group of 15 422 subjects aged 45-64 years and screened in Renfrew and Paisley between 1972 and 1976, and a group of hypertensives seen in a blood pressure clinic based on general practice in Renfrew. Average blood pressure for men at entry to the Glasgow Clinic was 181/111 mmHg falling to 158/96 mmHg during treatment. Corresponding values for women were 185/109 mmHg and 161/96 mmHg. Seven hundred and fifty clinic patients (451 males) died during follow-up, the commonest causes of death in both sexes being myocardial infarction and stroke. All-cause age-adjusted mortality (deaths per 1000 patient-years) was 41.4 for men and 22.1 for women. At all ages in both sexes and for all levels of initial blood pressure mortality was less in patients whose blood pressure was reduced most. Without a randomized control group it is not certain that lower mortality in those with well controlled blood pressure was due to treatment, although this is the most likely explanation. Cigarette smoking, a history of myocardial infarction, angina or stroke, retinal arterio-venous nipping, raised blood urea, an abnormal electrocardiogram (ECG) and secondary hypertension were associated with increased risk, but heavy alcohol intake, obesity, haematocrit greater than 45%, hypokalaemia and social class were not. Life table analysis showed that, despite some reduction of mortality by treatment, the relative risk to men and women in the clinic remained two- to five-times that of the general population. The benefits of treatment were not such as to restore normal expectation of life even when blood pressure was well controlled. Excess mortality in the clinic could not be explained by difference of smoking habit or social class. This suggests that there is in the hypertensive patients of the Glasgow Clinic an element of irreducible risk, that treatment may be beneficial in some respects but harmful in others, or that patients at particularly high risk are selectively referred to the clinic.

摘要

1968年至1983年间,3783名前往格拉斯哥血压诊所就诊的非恶性高血压患者接受了平均6.5年的随访,其死亡率与三个对照组进行了比较:斯特拉斯克莱德的普通人群、1972年至1976年间在伦弗鲁和佩斯利筛查的15422名45至64岁的受试者组成的一组,以及在伦弗鲁基于全科医疗的血压诊所就诊的一组高血压患者。进入格拉斯哥诊所时,男性的平均血压为181/111 mmHg,治疗期间降至158/96 mmHg。女性的相应数值为185/109 mmHg和161/96 mmHg。750名诊所患者(451名男性)在随访期间死亡,男女最常见的死亡原因是心肌梗死和中风。全因年龄调整死亡率(每1000患者年的死亡人数)男性为41.4,女性为22.1。在所有年龄段的男女中,以及在所有初始血压水平上,血压降低最多的患者死亡率较低。由于没有随机对照组,虽然这是最有可能的解释,但血压控制良好者死亡率较低是否归因于治疗尚不确定。吸烟、有心肌梗死、心绞痛或中风病史、视网膜动静脉交叉压迫、血尿素升高、心电图(ECG)异常和继发性高血压与风险增加相关,但大量饮酒、肥胖、血细胞比容大于45%、低钾血症和社会阶层则无关。生命表分析表明,尽管治疗使死亡率有所降低,但诊所中男性和女性的相对风险仍是普通人群的两到五倍。即使血压得到良好控制,治疗的益处也不足以恢复正常的预期寿命。诊所中过高的死亡率无法用吸烟习惯或社会阶层的差异来解释。这表明,格拉斯哥诊所的高血压患者存在不可降低的风险因素,治疗在某些方面可能有益,但在其他方面可能有害,或者是特别高危的患者被选择性地转诊到了该诊所。

相似文献

1
Mortality in patients of the Glasgow Blood Pressure Clinic.格拉斯哥血压诊所患者的死亡率。
J Hypertens. 1986 Apr;4(2):141-56. doi: 10.1097/00004872-198604000-00003.
2
Low mortality from all causes, including myocardial infarction, in well-controlled hypertensives treated with a beta-blocker plus other antihypertensives.在接受β受体阻滞剂加其他抗高血压药物治疗的血压控制良好的高血压患者中,包括心肌梗死在内的各种原因导致的死亡率较低。
J Hypertens. 1987 Aug;5(4):489-98.
3
Left ventricular hypertrophy and mortality in hypertension: an analysis of data from the Glasgow Blood Pressure Clinic.高血压患者的左心室肥厚与死亡率:来自格拉斯哥血压诊所的数据分析
J Hypertens. 1990 Aug;8(8):775-82. doi: 10.1097/00004872-199008000-00012.
4
Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.经治疗的高血压患者中的中风和冠心病——一项长达三十年的前瞻性队列研究
J Intern Med. 2005 Jun;257(6):496-502. doi: 10.1111/j.1365-2796.2005.01497.x.
5
Trends in population blood pressure and determinant factors for population blood pressure.人群血压趋势及人群血压的决定因素
Dan Med J. 2017 Mar;64(3).
6
The Role of Beta-Blockers in the Treatment of Hypertension.β受体阻滞剂在高血压治疗中的作用
Adv Exp Med Biol. 2017;956:149-166. doi: 10.1007/5584_2016_36.
7
Hypertension evaluation and management in new young patients: are we doing our female patients a disservice?新年轻患者的高血压评估和管理:我们是否对女性患者有失公平?
Blood Press. 2024 Dec;33(1):2387909. doi: 10.1080/08037051.2024.2387909. Epub 2024 Aug 5.
8
Why do lean hypertensives have higher mortality rates than other hypertensives? Findings of the Hypertension Detection and Follow-up Program.为什么瘦型高血压患者的死亡率高于其他高血压患者?高血压检测与随访项目的研究结果。
Hypertension. 1991 Apr;17(4):553-64. doi: 10.1161/01.hyp.17.4.553.
9
Haematocrit in patients attending a hypertension clinic.高血压诊所患者的血细胞比容。
Scott Med J. 1985 Jul;30(3):168-72. doi: 10.1177/003693308503000309.
10
Relationships between treated hypertension and subsequent mortality in an insured population.
J Insur Med. 2004;36(1):16-26.

引用本文的文献

1
Cardiovascular morbidity of severe resistant hypertension among treated uncontrolled hypertensives: a 4-year follow-up study.治疗未控制的高血压患者中重度难治性高血压的心血管发病率:一项 4 年随访研究。
J Hum Hypertens. 2018 Jul;32(7):487-493. doi: 10.1038/s41371-018-0065-y. Epub 2018 May 1.
2
Risk factor assessment of stroke and its awareness among stroke survivors: A prospective study.中风幸存者的中风风险因素评估及其认知:一项前瞻性研究。
Adv Biomed Res. 2015 Aug 31;4:187. doi: 10.4103/2277-9175.164011. eCollection 2015.
3
Difference in left ventricular mass index between hypertensive patients with and without renal artery stenosis by propensity score analysis.
通过倾向评分分析比较有和没有肾动脉狭窄的高血压患者左心室质量指数的差异。
J Clin Hypertens (Greenwich). 2014 Aug;16(8):606-11. doi: 10.1111/jch.12368. Epub 2014 Jul 14.
4
Clinical outcomes and effectiveness of renal artery stenting in patients with critical atherosclerotic renal artery stenosis: does it improve blood pressure control and renal function assessed by estimated glomerular filtration rate?严重动脉粥样硬化性肾动脉狭窄患者肾动脉支架置入术的临床结局及有效性:它能否改善血压控制及通过估算肾小球滤过率评估的肾功能?
Postepy Kardiol Interwencyjnej. 2013;9(3):228-33. doi: 10.5114/pwki.2013.37500. Epub 2013 Sep 16.
5
What is the predictive value of established risk factors for total and cardiovascular disease mortality when measured before middle age? Pooled analyses of two prospective cohort studies from Scotland.中年之前所测量的既定风险因素对于全因死亡率和心血管疾病死亡率的预测价值是什么?来自苏格兰的两项前瞻性队列研究的汇总分析。
Eur J Cardiovasc Prev Rehabil. 2010 Feb;17(1):106-12. doi: 10.1097/HJR.0b013e3283348ed9.
6
Early detection and management of the high-risk patient with elevated blood pressure.高血压高危患者的早期检测与管理。
Vasc Health Risk Manag. 2008;4(2):289-96. doi: 10.2147/vhrm.s930.
7
CD39/NTPDase-1 activity and expression in normal leukocytes.CD39/NTPDase-1在正常白细胞中的活性与表达
Thromb Res. 2007;121(3):309-17. doi: 10.1016/j.thromres.2007.04.008. Epub 2007 Jun 7.
8
Does the aldosterone:renin ratio predict the efficacy of spironolactone over bendroflumethiazide in hypertension? A clinical trial protocol for RENALDO (RENin-ALDOsterone) study.醛固酮与肾素比值能否预测螺内酯对比苄氟噻嗪治疗高血压的疗效?一项关于RENALDO(肾素 - 醛固酮)研究的临床试验方案。
BMC Cardiovasc Disord. 2007 May 9;7:14. doi: 10.1186/1471-2261-7-14.
9
Life-years gained from modern cardiological treatments and population risk factor changes in England and Wales, 1981-2000.1981 - 2000年英格兰和威尔士现代心脏病治疗及人群风险因素变化所带来的生命年增益
Am J Public Health. 2005 Jan;95(1):103-8. doi: 10.2105/AJPH.2003.029579.
10
The role of olmesartan medoxomil in the management of hypertension.奥美沙坦酯在高血压管理中的作用。
Drugs. 2004;64(24):2731-9. doi: 10.2165/00003495-200464240-00002.